Patent Challenges
FTC is looking to ban reverse-payment settlements and pharma must tread with caution.
How to Fight Medicare Reform
Experts offer strategies for blocking repeal of non-interference bill.
Pfizer When It Fizzles
Kindler's Strategic Direction Is Neither, Say Cranky Analysts
